BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32206953)

  • 21. [SENTINEL LYMPH NODE BIOPSY AND AXILLARY DISSECTION].
    Takahashi M
    Nihon Geka Gakkai Zasshi; 2016 Nov; 117(6):509-15. PubMed ID: 30173475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sentinel node biopsy to avoid axillary lymph node dissection in breast cancer.
    Motomura K; Komoike Y; Nagumo S; Kasugai T; Hasegawa Y; Inaji H; Noguchi S; Koyama H
    Breast Cancer; 2002; 9(4):337-43. PubMed ID: 12459716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sentinel lymph node biopsy as an alternative to routine axillary lymph node dissection in breast cancer patients.
    Cady B
    J Surg Oncol; 2001 Jul; 77(3):149-52. PubMed ID: 11455549
    [No Abstract]   [Full Text] [Related]  

  • 24. Sentinel node biopsy is not an alternative to axillary dissection in breast cancer.
    Moffat FL
    J Surg Oncol; 2001 Jul; 77(3):153-6. PubMed ID: 11455550
    [No Abstract]   [Full Text] [Related]  

  • 25. Axillary lymph node dissection using a robotic surgical system: Initial experience.
    Lee J; Park HS; Lee H; Lee K; Han DH; Lee DW
    J Surg Oncol; 2020 Nov; 122(6):1252-1256. PubMed ID: 32783194
    [No Abstract]   [Full Text] [Related]  

  • 26. Breast cancer patients with extra-axillary sentinel nodes only may be spared axillary lymph node dissection.
    van der Ploeg IM; Tanis PJ; Valdés Olmos RA; Kroon BB; Rutgers EJ; Nieweg OE
    Ann Surg Oncol; 2008 Nov; 15(11):3239-43. PubMed ID: 18773244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing Observation, Axillary Radiotherapy, and Completion Axillary Lymph Node Dissection for Management of Axilla in Breast Cancer in Patients with Positive Sentinel Nodes: A Systematic Review.
    Castelo M; Hu SY; Dossa F; Acuna SA; Scheer AS
    Ann Surg Oncol; 2020 Aug; 27(8):2664-2676. PubMed ID: 32020394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Observational study of axilla treatment for breast cancer patients with 1-3 positive micrometastases or macrometastases in sentinel lymph nodes.
    Oba MS; Imoto S; Toh U; Wada N; Kawada M; Kitada M; Masuda N; Taguchi T; Minami S; Jinno H; Sakamoto J; Morita S;
    Jpn J Clin Oncol; 2014 Sep; 44(9):876-9. PubMed ID: 25030214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The State of Surgical Axillary Management and Adjuvant Radiotherapy for Early-stage Invasive Breast Cancer in the Modern Era.
    Mann JM; Wu X; Christos P; Nagar H
    Clin Breast Cancer; 2018 Aug; 18(4):e477-e493. PubMed ID: 29031423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Axillary nodal yields: a comparison between primary clearance and completion clearance after sentinel lymph node biopsy in the management of breast cancer.
    Chakravorty A; Sanmugalingam N; Shrestha A; Thomee E; Rusby J; Roche N; MacNeill F
    Eur J Surg Oncol; 2011 Feb; 37(2):122-6. PubMed ID: 21095094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sentinel node biopsy versus low axillary sampling in women with clinically node negative operable breast cancer.
    Parmar V; Hawaldar R; Nair NS; Shet T; Vanmali V; Desai S; Gupta S; Rangrajan V; Mittra I; Badwe RA
    Breast; 2013 Dec; 22(6):1081-6. PubMed ID: 23948301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Axillary recurrence in breast cancer patients with isolated tumor cells in the sentinel lymph node [AJCC N0(i+)].
    Degnim AC; Zakaria S; Boughey JC; Sookhan N; Reynolds C; Donohue JH; Farley DR; Grant CS; Hoskin T
    Ann Surg Oncol; 2010 Oct; 17(10):2685-9. PubMed ID: 20390457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Which sentinel lymph-node (SLN) positive breast cancer patient needs an axillary lymph-node dissection (ALND)--ACOSOG Z0011 results and beyond.
    Gatzemeier W; Mann GB
    Breast; 2013 Jun; 22(3):211-6. PubMed ID: 23478200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ASO Author Reflections: Positive Sentinel Lymph Node in Breast Cancer Surgery.
    Millen EC; Cavalcante FP
    Ann Surg Oncol; 2022 Feb; 29(2):1096-1097. PubMed ID: 34561776
    [No Abstract]   [Full Text] [Related]  

  • 35. Is there a need for axillary dissection in breast cancer?
    Wilson JP; Mattson D; Edge SB
    J Natl Compr Canc Netw; 2011 Feb; 9(2):225-30. PubMed ID: 21310843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positive sentinel lymph node: New controversies regarding axillary node dissection.
    Rubio IT
    J Surg Oncol; 2006 Jun; 93(7):517-8. PubMed ID: 16705727
    [No Abstract]   [Full Text] [Related]  

  • 37. ASO Author Reflections: Radiation or Completion Dissection for the Lymph Node Basin in Micrometastatic Merkel Cell Carcinoma: A National Cohort.
    Ma KL; Karakousis GC; Miura JT
    Ann Surg Oncol; 2023 Jul; 30(7):4356. PubMed ID: 37115370
    [No Abstract]   [Full Text] [Related]  

  • 38. Have the American College of Surgeons Oncology Group Z0011 trial results influenced the number of lymph nodes removed during sentinel lymph node dissection?
    Robinson KA; Pockaj BA; Wasif N; Kaufman K; Gray RJ
    Am J Surg; 2014 Dec; 208(6):1060-4; discussion 1063-4. PubMed ID: 25312842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of axillary disease.
    Caudle AS; Cupp JA; Kuerer HM
    Surg Oncol Clin N Am; 2014 Jul; 23(3):473-86. PubMed ID: 24882346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality of life after sentinel lymph node biopsy versus complete axillary lymph node dissection in early breast cancer: a 3-year follow-up study.
    Boguševičius A; Čepulienė D
    Medicina (Kaunas); 2013; 49(3):111-7. PubMed ID: 23893054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.